6th Microbiome Movement - Drug Development Summit Europe
Evvnt Promotion / evvnt
Archiv
25.01.2022 - 27.01.2022 Online, Großbritannien
Time: 10:00 AM - 5:50 PM
Kongressthemen
As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effective treatments that target the human microbiome is still limited by the complex challenges in developing them.
As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effective treatments that target the human microbiome is still limited by the complex challenges in developing them.
Kongressorganizer (PCO)
Hanson Wade
Hanson Wade
Anfragen und Anmeldung:
https://go.evvnt.com/919896-2?pid=4832
Frau Emily Lincoln
Allgemeinmedizin
Sprache
Englisch
Englisch
Kongressgebühr
Drug Developer - Conference Only (digital) GBP 1549.00, Academic - Conference Only (digital) GBP 1299.00, Solution & Service Provider - Conference Only (digital) GBP 1899.00
Drug Developer - Conference Only (digital) GBP 1549.00, Academic - Conference Only (digital) GBP 1299.00, Solution & Service Provider - Conference Only (digital) GBP 1899.00
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
